This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
Smart Money Going in Senior Health: Key Stocks in Elderly Care
by Urmimala Biswas
RHHBY, NVO, EW and SYK are ramping up senior care innovation as aging populations reshape global healthcare demand.
ABTNegative Net Change RHHBYPositive Net Change NVOPositive Net Change MDTPositive Net Change SYKNegative Net Change EWNegative Net Change
healthcare medical medical-devices pharmaceuticals
Here's Why You Should Add Cencora Stock to Your Portfolio Now
by Zacks Equity Research
COR gains on strong GLP-1 and specialty drug growth, but margin pressure and fierce competition pose ongoing risks.
CVSNegative Net Change CORPositive Net Change CODXNegative Net Change WGSPositive Net Change
medical medical-devices
OptimizeRx Bets on AI and Workflow Integration: Will This Pay Off?
by Indrajit Bandyopadhyay
OPRX doubles down on AI and subscriptions, but margin mix and retention risks loom over its platform transformation.
OPRXPositive Net Change HSTMPositive Net Change DOCSNegative Net Change
medical medical-devices
3 AI-Driven Medical Device Stocks to Watch in 2025
by Sridatri Sarkar
BSX, JNJ and GEHC are leveraging AI to boost device performance, diagnostics and surgical precision in 2025.
BSXPositive Net Change JNJPositive Net Change ISRGPositive Net Change NVDAPositive Net Change GEHCNegative Net Change
medical medical-devices
Reasons to Add Fresenius Medical Stock to Your Portfolio Now
by Zacks Equity Research
FMS continues to gain traction on the back of acquisitions & partnerships. A tough regulatory environment raises concerns.
FMSNegative Net Change CORPositive Net Change ITGRPositive Net Change HIMSNegative Net Change
medical medical-devices
Shore Bancshares (SHBI) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
SHBIPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Origin Bancorp (OBK) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
OBKNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Hologic's GYN Surgical Dominance: What's Powering the Road Ahead?
by Moumi Mondal
HOLX's GYN Surgical arm gains momentum with Fluent Pro, global expansion and strategic acquisitions fueling growth.
JNJPositive Net Change MDTPositive Net Change HOLXPositive Net Change
medical medical-devices
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
by Zacks Equity Research
CNMD stock rides high on strong recurring revenues, margin gains, and surgical product growth despite supply and cybersecurity challenges.
CNMDNegative Net Change CVSNegative Net Change CORPositive Net Change WGSPositive Net Change
medical medical-devices
Should You Continue to Hold STERIS Stock in Your Portfolio Now?
by Zacks Equity Research
STE rides on strong Healthcare and AST growth, but macro pressures and customer consolidation cloud its outlook.
CAHPositive Net Change CORPositive Net Change STEPositive Net Change PAHCPositive Net Change
medical medical-devices
Top Research Reports for SAP, Novo Nordisk & Thermo Fisher
by Mark Vickery
SAP gains on cloud strength, NVO faces obesity setbacks, and TMO leans on AI and innovation amid macro headwinds.
NVOPositive Net Change TMOPositive Net Change SAPNegative Net Change PSXPositive Net Change CGPositive Net Change HUBSNegative Net Change HURCPositive Net Change FONRPositive Net Change
computers industrial-products medical medical-devices pharmaceuticals
AMN Stock Gains Post Latest Deals With symplr to Boost Operations
by Zacks Equity Research
AMN Healthcare sells Smart Square to symplr for $75 million and forms a new technology partnership aimed at boosting scheduling efficiency.
BSXPositive Net Change CORPositive Net Change AMNPositive Net Change ITGRPositive Net Change
medical medical-devices
Here's Why You Should Add PacBio Stock to Your Portfolio Now
by Zacks Equity Research
PACB benefits from strong first-quarter results, product innovation, and cost cuts to offset macroeconomic concerns and drive 2025 growth.
CORPositive Net Change PACBPositive Net Change ITGRPositive Net Change HIMSNegative Net Change
medical medical-devices
Veeva Expands Market Reach Through Targeted Strategic Partnerships
by Harshit Gupta
VEEV gains momentum in 2025 with strategic partnerships fueling growth in AI, clinical research, and compliance.
ORCLNegative Net Change VEEVPositive Net Change IQVPositive Net Change
medical medical-devices
Korn/Ferry (KFY) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
KFYNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Dell Technologies (DELL) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
DELLNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
After Golden Cross, East West Bancorp (EWBC)'s Technical Outlook is Bright
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
EWBCPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Industrial Logistics Properties Trust (ILPT) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
ILPTNo Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Continue to Hold Thermo Fisher Stock in Your Portfolio Now?
by Zacks Equity Research
TMO's growth via acquisitions and product launches is strong, but macro pressures and FX headwinds cloud the outlook.
TMOPositive Net Change CAHPositive Net Change CORPositive Net Change PAHCPositive Net Change
medical medical-devices
Glaukos Ramps Up iDose TR, Battles Legacy and Reimbursement Risks
by Zacks Equity Research
GKOS posts record Q1 on iDose TR strength, but reimbursement hurdles and legacy declines may hurt its near-term outlook.
JNJPositive Net Change ALCPositive Net Change GKOSPositive Net Change SGHTPositive Net Change
medical medical-devices
Is CVS Moving Closer to Reaching Its Long-Term Low 3X Leverage Goal?
by Moumi Mondal
CVS Health inches closer to its long-term leverage target, helped by Aetna margin recovery and disciplined cash use.
UNHNegative Net Change CINegative Net Change CVSNegative Net Change
medical medical-devices
Is the Options Market Predicting a Spike in AdaptHealth Stock?
by Zacks Equity Research
Investors need to pay close attention to AHCO stock based on the movements in the options market lately.
AHCOPositive Net Change
medical medical-devices
VEEV Rises 29% in 3 Months: Should You Buy the Stock Now or Wait?
by Harshit Gupta
Veeva Systems gains momentum as strong earnings, Vault CRM growth, and new AI tools reinforce its life sciences edge.
VEEVPositive Net Change IQVPositive Net Change HCATPositive Net Change CERTNegative Net Change
medical medical-devices
Bank OZK (OZK) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
OZKPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Is Hologic Stock's Low Valuation an Opportunity or a Value Trap?
by Moumi Mondal
HOLX trades below peers on P/S, but falling EPS, weak Breast Health sales and China risks cloud the outlook.
ABTNegative Net Change HOLXPositive Net Change QGENNegative Net Change
medical medical-devices